Deciphering immune cell heterogeneity in vascular diseases: Insights from single-cell sequencing
Weirong Zeng1, Yu Zhang1, Wanyue Zhong1
1Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
International Immunopharmacology
|April 30, 2025
Summary
Single-cell sequencing reveals new immune cell roles in vascular diseases, offering insights into inflammation and potential therapeutic targets for better treatment strategies.
Area of Science:
- Immunology
- Vascular Biology
- Genomics
Background:
- Vascular diseases involve complex immune responses, but immune cell dynamics and interactions are not fully understood.
- Existing reviews lack comprehensive details on immune cell heterogeneity and functional states in vascular pathology.
- Single-cell sequencing (SCS) offers a powerful tool to dissect immune cell complexity in disease.
Purpose of the Study:
- To systematically review the recent applications of SCS in understanding vascular diseases.
- To highlight novel immune cell subsets, their interactions, and their impact on vascular pathology.
- To address knowledge gaps regarding immune cell plasticity and temporal dynamics in vascular diseases.
Main Methods:
- Systematic literature review focusing on studies utilizing single-cell sequencing (SCS) in vascular diseases.
- Analysis of identified immune cell subpopulations and their functional states.
- Examination of intercellular communication networks within the vascular microenvironment.
Main Results:
- SCS has identified previously unknown immune cell subsets contributing to vascular pathology.
- New insights into the functional plasticity and dynamic changes of immune cells in vascular diseases.
- Characterization of specific immune cell interactions driving inflammatory processes in vascular diseases.
Conclusions:
- SCS provides a high-resolution view of immune cell involvement in vascular diseases.
- Understanding immune cell heterogeneity and dynamics is crucial for developing targeted therapies.
- This review proposes novel therapeutic strategies based on SCS findings for vascular disease prevention and treatment.


